16
Participants
Start Date
April 21, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Ketanserin 40mg plus Psilocybin 40mg
40mg Ketanserin oral will be administered followed by 40mg Psilocybin.
40mg Psilocybin
Placebo oral followed by 40mg Psilocybin one hour later.
20mg Psilocybin
Placebo oral followed by 20mg Psilocybin one hour later.
10mg Psilocybin
Placebo oral followed by 10mg Psilocybin oral one hour later.
5mg Psilocybin
Placebo oral followed by 5mg Psilocybin one hour later
Placebo
Oral Placebo followed by oral Placebo one hour later
RECRUITING
Clinical Trial Unit, Basel
University Hospital, Basel, Switzerland
OTHER